Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

GLUEGLUE
Showing 8 of 20 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in MONTE ROSA THERAPEUTICS INC

NORTHERN TRUST CORP holds 652,087 shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $15.8M as of 2026-Q2. The position was decreased (-21.1% shares). GLUE represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$15.8M

Current Shares

652,087

Total Value Change

+$13.9M

Total Shares Change

+293,514

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
652,087
-21.1%
$15.8M0.0%$24.20
0
2026-Q1
Increased
826,624
+18.6%
$13.6M0.0%$17.96
33
2025-Q4
Decreased
697,034
-5.9%
$10.9M0.0%$15.97
0
2025-Q3
Decreased
740,684
-2.7%
$5.5M0.0%$7.31
0
2025-Q2
Increased
761,419
+104.0%
$3.4M0.0%$4.60
43
2025-Q1
Decreased
373,207
-1.0%
$1.7M0.0%$5.10
0
2024-Q4
Increased
376,964
+5.1%
$2.6M0.0%$7.02
28
2024-Q3
Increased
358,573
+21.9%
$1.9M0.0%$5.17
31

Other major holders of GLUE: BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used